MATTHEW TILEM, MD
Vascular Neurology Physician in BURLINGTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MATTHEW TILEM, MD reported a CMS MIPS final score of 91.4157/100 — above the 83.1 national average — and filed 1,018 Medicare Part D claims in 2023.
- 91.4157/100
- MIPS score · +8 vs avg
- 1K
- Part D claims, 2023
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MATTHEW TILEM, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MATTHEW TILEM, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MATTHEW TILEM, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Massachusetts
How Vascular Neurology Physician compares to other specialties among Massachusetts providers
Vascular Neurology Physician share within Massachusetts
Vascular Neurology Physician is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MATTHEW TILEM, MD's 2023 MIPS final score plotted against the Vascular Neurology Physician national average
- MIPS Final Score
- 91.4157/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Vascular Neurology Physician) — 91.4157/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Vascular Neurology Physician US NPIs
91.4157/100 MIPS final score — 8.3 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Vascular Neurology Physician. Quality dim: 76.877.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MATTHEW TILEM, MD appears in the CMS NPPES registry as a Vascular Neurology Physician provider holding MD credentials at LAHEY CLINIC, BURLINGTON, MA, 01805, with a listed phone of (781) 744-8000. NPI 1033202353 was issued on 09/30/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TILEM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,018 prescription claims written by this provider, covering 240 Medicare beneficiaries and totaling roughly $125K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4157/100 for the 2023 performance year (Quality 76.877), compared with the national average of 83.1.
Vascular Neurology Physician is a narrow specialty nationwide, with 555 enrolled providers across 47 states and an average of 378 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1033202353 |
|---|---|
| Specialty | Vascular Neurology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 09/30/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MATTHEW TILEM, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where MATTHEW TILEM, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MATTHEW TILEM, MD. To verify MATTHEW TILEM, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
11% brand-name claims vs 89% generic, on 1,018 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,894
- Total Day Supply
- 56,021
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $95K
- Generic Drug Cost
- $30K
Patient Demographics
- Average Patient Age
- 75.3 years
- Avg HCC Risk Score
- 1.43
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 27, 65-74: 65, 75-84: 106, 85+: 42
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MATTHEW TILEM, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
99 claims
- Donepezil Hcl
Donepezil Hcl
95 claims
- Levetiracetam
Levetiracetam
89 claims
- Memantine Hcl
Memantine Hcl
76 claims
- Atorvastatin Calcium
Atorvastatin Calcium
53 claims
- Eliquis
Eliquis
41 claims
- Nortriptyline Hcl 39
Nortriptyline Hcl
39 claims
- Carbidopa-Levodopa 37
Carbidopa-Levodopa
37 claims
| Drug | Claims |
|---|---|
| Gabapentin | 99 |
| Donepezil Hcl | 95 |
| Levetiracetam | 89 |
| Memantine Hcl | 76 |
| Atorvastatin Calcium | 53 |
| Eliquis Apixaban | 41 |
| Nortriptyline Hcl | 39 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 37 |
| Clopidogrel Clopidogrel Bisulfate | 24 |
| Oxcarbazepine | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Vascular Neurology Physician Overview
How MATTHEW TILEM, MD fits within the Vascular Neurology Physician landscape nationally.
MATTHEW TILEM, MD's 1,018 claims are above the specialty average of 378.
Nearby Vascular Neurology Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as TILEM.
Compare Vascular Neurology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is MATTHEW TILEM, MD's specialty? ▼
How much does MATTHEW TILEM, MD prescribe under Medicare Part D? ▼
What is MATTHEW TILEM, MD's Medicare quality score? ▼
Where is MATTHEW TILEM, MD located? ▼
What is MATTHEW TILEM, MD's NPI number? ▼
Does MATTHEW TILEM, MD prescribe more brand-name or generic drugs? ▼
How many Vascular Neurology Physician providers are there in the US? ▼
What drugs does MATTHEW TILEM, MD prescribe most often? ▼
Does MATTHEW TILEM, MD accept Medicare? ▼
How can I verify MATTHEW TILEM, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology